Kennedy Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,748
| Closed | -$292K | – | 767 |
|
|
2024
Q1 | $292K | Sell |
55,748
-18,061
| -24% | -$94.6K | 0.01% | 679 |
|
|
2023
Q4 | $386K | Buy |
73,809
+37,323
| +102% | +$195K | 0.01% | 644 |
|
|
2023
Q3 | $575K | Buy |
+36,486
| New | +$575K | 0.01% | 606 |
|
|
2021
Q4 | – | Sell |
-96,191
| Closed | -$5.37M | – | 651 |
|
|
2021
Q3 | $5.37M | Sell |
96,191
-4,513
| -4% | -$252K | 0.12% | 322 |
|
|
2021
Q2 | $4.31M | Sell |
100,704
-12,476
| -11% | -$534K | 0.09% | 383 |
|
|
2021
Q1 | $4.72M | Buy |
+113,180
| New | +$4.72M | 0.1% | 383 |
|